Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Douglas

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|August 20, 2016
Substance P and sickle cell disease-a marker for pain and novel therapeutic approachesSteven D Douglas
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
NIMH Preclinical/Clinical Therapeutics Research meeting--preclinical drug discovery sessionSteven D Douglas
Brain, Behavior, and Immunity|December 8, 2004
Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactionsSteven D Douglas
The Journal of Pediatrics|December 17, 2005
Down syndrome: immunologic and epidemiologic associations-enigmas remainSteven D Douglas
Medical Hypotheses|February 19, 2008
Elevated plasma substance P in sickle cell disease and vaso-occlusive crisisSteven D Douglas
Journal of Leukocyte Biology|November 3, 2017
Editorial: Gateway to monocyte entry into the brain: CXCR7, the new orchestra conductorSteven D Douglas, Sergei Spitsin
Annals of the New York Academy of Sciences|November 25, 2010
Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammationSteven D Douglas, Susan E Leeman
Journal of Neuroimmunology|December 8, 2004
Substance P and neurokinin-1 receptor modulation of HIVWen-Zhe Ho, Steven D Douglas
The Journal of Allergy and Clinical Immunology|July 1, 2018
Is substance P a nasal epithelial neuropeptide?Steven D Douglas, Susan E Leeman
Journal of Leukocyte Biology|January 19, 2018
Truncation of neurokinin-1 receptor-Negative regulation of substance P signalingSergei Spitsin, Vasiliki Pappa, Steven D Douglas
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|August 20, 2016
Substance P and sickle cell disease-a marker for pain and novel therapeutic approachesSteven D Douglas
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
NIMH Preclinical/Clinical Therapeutics Research meeting--preclinical drug discovery sessionSteven D Douglas
Brain, Behavior, and Immunity|December 8, 2004
Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactionsSteven D Douglas
The Journal of Pediatrics|December 17, 2005
Down syndrome: immunologic and epidemiologic associations-enigmas remainSteven D Douglas
Medical Hypotheses|February 19, 2008
Elevated plasma substance P in sickle cell disease and vaso-occlusive crisisSteven D Douglas
Journal of Leukocyte Biology|November 3, 2017
Editorial: Gateway to monocyte entry into the brain: CXCR7, the new orchestra conductorSteven D Douglas, Sergei Spitsin
Annals of the New York Academy of Sciences|November 25, 2010
Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammationSteven D Douglas, Susan E Leeman
Journal of Neuroimmunology|December 8, 2004
Substance P and neurokinin-1 receptor modulation of HIVWen-Zhe Ho, Steven D Douglas
The Journal of Allergy and Clinical Immunology|July 1, 2018
Is substance P a nasal epithelial neuropeptide?Steven D Douglas, Susan E Leeman
Journal of Leukocyte Biology|January 19, 2018
Truncation of neurokinin-1 receptor-Negative regulation of substance P signalingSergei Spitsin, Vasiliki Pappa, Steven D Douglas
Pageof 14